Enzalutamide in European and North American men participating in the AFFIRM trial

OBJECTIVE: To explore any differences in efficacy and safety outcomes between European (EU) (n = 684) and North American (NA) (n = 395) patients in the AFFIRM trial (NCT00974311). PATIENTS AND METHODS: Phase III, double-blind, placebo-controlled, multinational AFFIRM trial in men with metastatic cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Merseburger, Axel S, Scher, Howard I, Bellmunt, Joaquim, Miller, Kurt, Mulders, Peter FA, Stenzl, Arnulf, Sternberg, Cora N, Fizazi, Karim, Hirmand, Mohammad, Franks, Billy, Haas, Gabriel P, de Bono, Johann, de Wit, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2015
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312486/
https://www.ncbi.nlm.nih.gov/pubmed/25123978
http://dx.doi.org/10.1111/bju.12898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312486/
https://www.ncbi.nlm.nih.gov/pubmed/25123978
http://dx.doi.org/10.1111/bju.12898

Ejemplares similares